
eBook - ePub
Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies
- 828 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies
About this book
Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies brings current knowledge from an international team of experts on the science and clinical management of glioblastoma chemoresistance. The book discusses topics such as molecular mechanisms of chemoresistance, experimental models to study chemoresistance, chemoresistance to drugs other than Temozolomide, and specific strategies to reverse chemoresistance. Additionally, it encompasses information on how to mitigate chemoresistance by targeted enhancement of p53 function. This book is a valuable resource for cancer researchers, oncologists, neuro-oncologists and other members of the biomedical field.
Glioblastoma (GBM) is the most invasive and malignant primary brain tumor in humans with poor survival after diagnosis, therefore it is imperative that molecular and cellular mechanisms behind therapy resistant GBM cells, as well as the therapeutic strategies available to counter the resistance are comprehensively understood.
- Provides comprehensive, core knowledge related to the entire discipline of glioblastoma chemoresistance, from its many etiological mechanisms, to specific strategies to reverse resistance
- Presents current information from an international team of experts on the basic science, pre-clinical research, and clinical management of glioblastoma chemoresistance
- Discusses molecular and cellular mechanisms behind therapy resistant glioblastoma cells, as well as the therapeutic strategies available to counter this resistance
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies by Ramasamy Paulmurugan,Tarik F. Massoud in PDF and/or ePUB format, as well as other popular books in Biological Sciences & Biology. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Cover
- Front Matter
- Table of Contents
- Copyright
- Cover Image Legend
- Aims and Scope for Series “Cancer Sensitizing Agents for Chemotherapy”
- About the Series Editor
- Aims and Scope of the Volume
- About the Volume Editors
- Preface
- Contributors
- List of Illustrations
- List of Tables
- Chapter 1 : Overview of glioblastoma biological hallmarks and molecular pathology
- Chapter 2 : Past and present drug treatments for glioblastoma
- Chapter 3 : Investigational new drugs against glioblastoma
- Chapter 4 : Molecular mechanisms in temozolomide-resistant glioblastoma
- Chapter 5 : Glioma stem cells and associated molecular mechanisms in Glioblastoma Chemoresistance
- Chapter 6 : Signaling in the tumor microenvironment of therapy-resistant glioblastoma
- Chapter 7 : Intratumoral heterogeneity associated with glioblastoma drug response and resistance
- Chapter 8 : Role of apoptosis, autophagy, and the unfolded protein response in glioblastoma chemoresistance
- Chapter 9 : Role of multidrug resistance in glioblastoma chemoresistance: Focus on ABC transporters
- Chapter 10 : Role of mitochondrial reactive oxygen species in glioblastoma drug resistance and strategies for therapeutic intervention
- Chapter 11 : Glioblastoma cell-induced immunosuppression causing chemoresistance
- Chapter 12 : Role of cell quiescence in glioblastoma cytotoxic resistance and strategies for therapeutic intervention
- Chapter 13 : The molecular and cellular effects of radiotherapy-induced microenvironment changes on potential chemoresistance in glioblastoma
- Chapter 14 : Molecular and cellular mechanisms in recurrent glioblastoma chemoresistance
- Chapter 15 : Role of long noncoding RNAs in temozolomide-resistant glioblastoma
- Chapter 16 : Mechanisms of glioblastoma resistance to antiangiogenic agents and reversal approaches
- Chapter 17 : Treatment and resistance of glioblastoma to CAR T-cell immunotherapies
- Chapter 18 : On-chip analysis of glioblastoma cell chemoresistance
- Chapter 19 : Three-dimensional in vitro models to study potentiation of glioblastoma resistance by hypoxia
- Chapter 20 : Chemoresistance mechanisms in mouse models of glioblastoma
- Chapter 21 : Therapeutic approaches to overcome temozolomide resistance in glioblastoma
- Chapter 22 : Understanding signal transduction pathways to overcome targeted therapy resistance in glioblastoma
- Chapter 23 : Targeting the molecular mechanisms of glioma stem cell resistance to chemotherapy
- Chapter 24 : Immunotherapy for glioblastoma as a means to overcome resistance to standard therapy
- Chapter 25 : Role of microRNA therapy in presensitizing glioblastoma cells to temozolomide treatment
- Chapter 26 : Drug penetration through the blood–brain barrier after radiotherapy: New approaches to bypass glioblastoma chemoresistance
- Chapter 27 : Nanoparticles beyond the blood-brain barrier for glioblastoma
- Chapter 28 : Small molecules targeting misfolded mutants of p53 as a rescue strategy to improve glioblastoma chemotherapy
- Chapter 29 : p53 supplementation as a targeted cancer gene therapy for glioblastoma
- Index
- A